nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Dalfampridine—Infestation—Methylprednisolone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Dalfampridine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Dalfampridine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00999	0.00999	CcSEcCtD
Dalfampridine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00995	0.00995	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00993	0.00993	CcSEcCtD
Dalfampridine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00965	0.00965	CcSEcCtD
Dalfampridine—Angioedema—Prednisolone—ankylosing spondylitis	0.00955	0.00955	CcSEcCtD
Dalfampridine—Back pain—Triamcinolone—ankylosing spondylitis	0.00929	0.00929	CcSEcCtD
Dalfampridine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00909	0.00909	CcSEcCtD
Dalfampridine—Angiopathy—Betamethasone—ankylosing spondylitis	0.00909	0.00909	CcSEcCtD
Dalfampridine—Convulsion—Prednisolone—ankylosing spondylitis	0.00905	0.00905	CcSEcCtD
Dalfampridine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00878	0.00878	CcSEcCtD
Dalfampridine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Dalfampridine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00857	0.00857	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00853	0.00853	CcSEcCtD
Dalfampridine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00832	0.00832	CcSEcCtD
Dalfampridine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00831	0.00831	CcSEcCtD
Dalfampridine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00813	0.00813	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00812	0.00812	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—ankylosing spondylitis	0.00812	0.00812	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Dalfampridine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00797	0.00797	CcSEcCtD
Dalfampridine—Angioedema—Betamethasone—ankylosing spondylitis	0.00797	0.00797	CcSEcCtD
Dalfampridine—Angiopathy—Prednisone—ankylosing spondylitis	0.00791	0.00791	CcSEcCtD
Dalfampridine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00789	0.00789	CcSEcCtD
Dalfampridine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00788	0.00788	CcSEcCtD
Dalfampridine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00784	0.00784	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00782	0.00782	CcSEcCtD
Dalfampridine—Infection—Triamcinolone—ankylosing spondylitis	0.00779	0.00779	CcSEcCtD
Dalfampridine—Infection—Methylprednisolone—ankylosing spondylitis	0.00777	0.00777	CcSEcCtD
Dalfampridine—Insomnia—Prednisolone—ankylosing spondylitis	0.00771	0.00771	CcSEcCtD
Dalfampridine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00767	0.00767	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00766	0.00766	CcSEcCtD
Dalfampridine—Mental disorder—Prednisone—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Dalfampridine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0076	0.0076	CcSEcCtD
Dalfampridine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00755	0.00755	CcSEcCtD
Dalfampridine—Convulsion—Betamethasone—ankylosing spondylitis	0.00755	0.00755	CcSEcCtD
Dalfampridine—Anxiety—Betamethasone—ankylosing spondylitis	0.0074	0.0074	CcSEcCtD
Dalfampridine—Anxiety—Dexamethasone—ankylosing spondylitis	0.0074	0.0074	CcSEcCtD
Dalfampridine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00731	0.00731	CcSEcCtD
Dalfampridine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00712	0.00712	CcSEcCtD
Dalfampridine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00712	0.00712	CcSEcCtD
Dalfampridine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00709	0.00709	CcSEcCtD
Dalfampridine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Dalfampridine—Infection—Dexamethasone—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Dalfampridine—Infection—Betamethasone—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Dalfampridine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00704	0.00704	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00703	0.00703	CcSEcCtD
Dalfampridine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00703	0.00703	CcSEcCtD
Dalfampridine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00699	0.00699	CcSEcCtD
Dalfampridine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00698	0.00698	CcSEcCtD
Dalfampridine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00698	0.00698	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—ankylosing spondylitis	0.00694	0.00694	CcSEcCtD
Dalfampridine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.0069	0.0069	CcSEcCtD
Dalfampridine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00689	0.00689	CcSEcCtD
Dalfampridine—Urticaria—Prednisolone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Dalfampridine—Hypotension—Betamethasone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Dalfampridine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Dalfampridine—Convulsion—Prednisone—ankylosing spondylitis	0.00658	0.00658	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Dalfampridine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00646	0.00646	CcSEcCtD
Dalfampridine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Dalfampridine—Anxiety—Prednisone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Dalfampridine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Dalfampridine—Insomnia—Betamethasone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00642	0.00642	CcSEcCtD
Dalfampridine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Dalfampridine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00628	0.00628	CcSEcCtD
Dalfampridine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00626	0.00626	CcSEcCtD
Dalfampridine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00626	0.00626	CcSEcCtD
Dalfampridine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00623	0.00623	CcSEcCtD
Dalfampridine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00622	0.00622	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0062	0.0062	CcSEcCtD
Dalfampridine—Infection—Prednisone—ankylosing spondylitis	0.00616	0.00616	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Dalfampridine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00608	0.00608	CcSEcCtD
Dalfampridine—Skin disorder—Prednisone—ankylosing spondylitis	0.00602	0.00602	CcSEcCtD
Dalfampridine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Dalfampridine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Dalfampridine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00578	0.00578	CcSEcCtD
Dalfampridine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00576	0.00576	CcSEcCtD
Dalfampridine—Urticaria—Betamethasone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Dalfampridine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Dalfampridine—Dizziness—Prednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Dalfampridine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Dalfampridine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—ankylosing spondylitis	0.0056	0.0056	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00556	0.00556	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—ankylosing spondylitis	0.0055	0.0055	CcSEcCtD
Dalfampridine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Dalfampridine—Rash—Prednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Dalfampridine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00537	0.00537	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Dalfampridine—Headache—Prednisolone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Dalfampridine—Constipation—Prednisone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Dalfampridine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Dalfampridine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Dalfampridine—Infection—Methotrexate—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00511	0.00511	CcSEcCtD
Dalfampridine—Asthenia—Betamethasone—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Dalfampridine—Asthenia—Dexamethasone—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Dalfampridine—Nausea—Prednisolone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Dalfampridine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Dalfampridine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Dalfampridine—Rash—Triamcinolone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Dalfampridine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Dalfampridine—Rash—Methylprednisolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Dalfampridine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Dalfampridine—Headache—Triamcinolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Dalfampridine—Headache—Methylprednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Dalfampridine—Dizziness—Betamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Dalfampridine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Dalfampridine—Nausea—Triamcinolone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Dalfampridine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Dalfampridine—Vomiting—Betamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Dalfampridine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Dalfampridine—Rash—Betamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Dalfampridine—Rash—Dexamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Dalfampridine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Dalfampridine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Dalfampridine—Headache—Dexamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Dalfampridine—Headache—Betamethasone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Dalfampridine—Asthenia—Prednisone—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Dalfampridine—Nausea—Dexamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Dalfampridine—Nausea—Betamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Dalfampridine—Dizziness—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Dalfampridine—Vomiting—Prednisone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Dalfampridine—Rash—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Dalfampridine—Headache—Prednisone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Dalfampridine—Nausea—Prednisone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Dalfampridine—Rash—Methotrexate—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Dalfampridine—Headache—Methotrexate—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
